Key result
Outpatient parenteral antimicrobial therapy linked to ~6.5-fold higher odds of IV antimicrobial completion vs. inpatient therapy.
Why the study?
Multiple models of care are available for managing invasive injecting-related infections, prompting this study to describe these infections and compare inpatient intravenous antimicrobials with outpatient parenteral antimicrobial therapy.
Does outpatient parenteral antimicrobial therapy (OPAT) improve confirmed completion of planned intravenous antimicrobials compared to inpatient intravenous antimicrobials in adults with invasive injecting-related infections?
Cohort (n=271)
Yes
Does outpatient parenteral antimicrobial therapy (OPAT) improve confirmed completion of planned intravenous antimicrobials compared to inpatient intravenous antimicrobials in adults with invasive injecting-related infections?
In people who inject drugs with invasive injecting-related infections (including infective endocarditis), outpatient parenteral antimicrobial therapy (OPAT) was associated with significantly higher odds of completing planned intravenous antimicrobial therapy compared to inpatient administration.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for OPAT in injecting-related infections; leaves open randomized confirmation before practice change.
Background Multiple models of care are available for the management of invasive injecting-related infections. Methods We conducted a multicentre, prospective cohort study at ten Australian hospitals (February 2022 - September 2024) to describe these infections and their management. Adults with an invasive infection and injecting drug use within the previous six months were eligible. The primary exposure was antimicrobial model of care, comparing inpatient intravenous antimicrobials with outpatient parenteral antimicrobial therapy (OPAT). The primary outcome was confirmed completion of planned intravenous antimicrobials among patients who did not die or initiate a patient-directed discharge within the first seven days, analysed using mixed effects multivariable logistic regression. Results Among 305 admissions (271 participants), median age was 46 years (IQR 39–52) and 68% were male (184/271). Unstable housing was common (25%, 73/305). Infective endocarditis occurred in 28% (86/305). Surgery (142/305, 47%) and intensive care (93/305, 31%) were frequently required. Patient-directed discharge occurred in 25% (76/305) and eviction in 3% (9/305). Inpatient mortality was 7% (21/305). Management with inpatient intravenous antimicrobials occurred in 52% (158/305), while 14% received OPAT (44/305). Smaller numbers received early oral antimicrobials or a long-acting lipoglycopeptide. OPAT was associated with increased odds of intravenous antimicrobial completion (adjusted OR 6.5, 95% confidence interval 1.4–29.3) versus inpatient intravenous antimicrobials. Conclusions Invasive injecting-related infections cause substantial morbidity and are frequently complicated by patient-directed discharge. OPAT was associated with higher odds of completing planned intravenous antimicrobial therapy, complementing emerging evidence supporting its use, where appropriate, as a treatment option for invasive injecting-related infections.
No takes yet. Share an insight, caveat, or question.
Attwood et al. (2026) conducted a cohort in Invasive injecting-related infections (including infective endocarditis) (n=271). Outpatient parenteral antimicrobial therapy (OPAT) vs. Inpatient intravenous antimicrobials was evaluated on Confirmed completion of planned intravenous antimicrobials among patients who did not die or initiate a patient-directed discharge within the first seven days (adjusted OR 6.5, 95% CI 1.4-29.3). Outpatient parenteral antimicrobial therapy was associated with increased odds of intravenous antimicrobial completion versus inpatient therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: